Mareev VIu

10.9k total citations · 1 hit paper
111 papers, 2.0k citations indexed

About

Mareev VIu is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Infectious Diseases. According to data from OpenAlex, Mareev VIu has authored 111 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Cardiology and Cardiovascular Medicine, 14 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Infectious Diseases. Recurrent topics in Mareev VIu's work include Heart Failure Treatment and Management (36 papers), Cardiovascular Function and Risk Factors (16 papers) and Cardiac pacing and defibrillation studies (12 papers). Mareev VIu is often cited by papers focused on Heart Failure Treatment and Management (36 papers), Cardiovascular Function and Risk Factors (16 papers) and Cardiac pacing and defibrillation studies (12 papers). Mareev VIu collaborates with scholars based in Russia, Tajikistan and United Kingdom. Mareev VIu's co-authors include Georg Ertl, Piotr Ponikowski, Theresa A. McDonagh, Stefan D. Anker, Alexander Parkhomenko, Frank Ruschitzka, Victoria Levesque, Luigi Tavazzi, Gerasimos Filippatos and Dirk J. van Veldhuisen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Mareev VIu

93 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency

2014 821 citations Georg Ertl, Mareev VIu et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mareev VIu Russia	17	1.3k	622	213	203	173	111	2.0k
Piotr Rozentryt Poland	20	1.3k 1.0×	749 1.2×	256 1.2×	272 1.3×	241 1.4×	92	2.6k
Constantinos G. Missouris United Kingdom	18	801 0.6×	606 1.0×	384 1.8×	233 1.1×	253 1.5×	87	1.9k
M Komajda France	12	2.2k 1.7×	577 0.9×	361 1.7×	180 0.9×	211 1.2×	25	2.8k
Pedro Moliner Spain	28	1.6k 1.2×	271 0.4×	200 0.9×	72 0.4×	199 1.2×	79	2.1k
Dov Wexler Israel	26	1.2k 0.9×	1.5k 2.5×	240 1.1×	431 2.1×	176 1.0×	39	2.5k
Sunil Nadar United Kingdom	25	1.0k 0.8×	174 0.3×	215 1.0×	77 0.4×	252 1.5×	89	1.9k
Paul R. Kalra United Kingdom	28	1.7k 1.3×	424 0.7×	558 2.6×	128 0.6×	434 2.5×	96	2.7k
Hiroki Hase Japan	19	466 0.4×	251 0.4×	171 0.8×	145 0.7×	254 1.5×	76	1.3k
Rossana Lombardi Italy	16	437 0.3×	592 1.0×	209 1.0×	129 0.6×	281 1.6×	27	1.5k
David Brosh Israel	21	1.2k 0.9×	474 0.8×	198 0.9×	117 0.6×	650 3.8×	52	2.1k

Countries citing papers authored by Mareev VIu

Since Specialization

Citations

This map shows the geographic impact of Mareev VIu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mareev VIu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mareev VIu more than expected).

Fields of papers citing papers by Mareev VIu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mareev VIu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mareev VIu. The network helps show where Mareev VIu may publish in the future.

Co-authorship network of co-authors of Mareev VIu

This figure shows the co-authorship network connecting the top 25 collaborators of Mareev VIu. A scholar is included among the top collaborators of Mareev VIu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mareev VIu. Mareev VIu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Виноградова, Н. Г., et al.. (2024). Laboratory Aspects of Using the Results of NT-Probnp Concentration Immunochemical Determination in the Management of Patients With Heart Failure: Support For Clinical Decision-Making. Kardiologiia. 64(8). 68–78.

Belenkov, Yu. N., G. P. Arutyunov, Mareev VIu, et al.. (2023). Prospects for use of Vericiguat in HFrEF: Implications of VICTORIA Trial Results. Advisory Board Summary. Kardiologiia. 63(4). 3–10. 2 indexed citations

Mareev, Yu. V., М. В. Ежов, S. V. Villevalde, et al.. (2023). Cardiovascular effects of omega-3 polyunsaturated fatty acids: position of omega-3 polyunsaturated fatty acids in Russian and international guidelines. Council of Experts. Kardiologiia. 63(2). 11–18. 2 indexed citations

VIu, Mareev, Yа. A. Orlova, Е.П. Павликова, et al.. (2020). Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT). Kardiologiia. 60(11). 4–15. 18 indexed citations

VIu, Mareev, Yа. A. Orlova, Е.П. Павликова, et al.. (2020). Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)”. Kardiologiia. 60(8). 4–15. 11 indexed citations

VIu, Mareev & Yu. V. Mareev. (2017). Role of heart rate in mechanisms of compensation and decompensation in CHF patients with sinus rhythm and atrial fibrillation and methods for safe and efficient control of heart rhythm. Part 2. Atrial fibrillation. Kardiologiia. 17(S2). 351–366.

Begrambekova, Yu. L., et al.. (2016). INFLUENCE OF PSYCHOEMOTIONAL DISORDERS ON THE EFFECTIVENESS OF EDUCATION AND ACTIVE OUTPATIENT CONTROL IN HEART FAILURE PATIENTS. Russian Journal of Cardiology. 48–52. 2 indexed citations

VIu, Mareev. (2016). Expert Council report “Importance of using omega-3 polyunsaturated fatty acid ethyl ethers (ω-3 PUFA 90 %, g/g) after myocardial infarction with concomitant cardiac abnormalities”. 15(4). 301–304. 1 indexed citations

Фомин, И. В., Yu. V. Badin, D. S. Polyakov, et al.. (2013). Prehypertension: How Often This Cardiovascular Condition Occurs in Citizens of European Russia (EPOCH -AH , 2002–2007). 5.

10.

Shen, Lan, Bimal R. Shah, Eric Reyes, et al.. (2012). Abstract 14642: Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study. Circulation. 126. 1 indexed citations

11.

Castagno, Davide, Erland Erdmann, Faı̈ez Zannad, et al.. (2011). Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II). Cardiovascular Drugs and Therapy. 25(1). 77–85. 10 indexed citations

12.

Castagno, Davide, Pardeep S. Jhund, John J.V. McMurray, et al.. (2010). Improved Survival with Bisoprolol in Patients with Heart Failure and Renal Impairment: An Analysis of the Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) Trial. European Journal of Heart Failure. 12(6). 607–616. 62 indexed citations

13.

VIu, Mareev. (2010). [Atorvastatin in the treatment of high risk patients with ischemic heart disease and dyslipidemia. Safety assessment in the Russian Multicenter Study ATLANTIKA].. PubMed. 50(9). 4–14. 2 indexed citations

14.

Khan, Nasrin, Kevin Goode, John G.F. Cleland, et al.. (2007). Prevalence of ECG Abnormalities in an International Survey of Patients with Suspected or Confirmed Heart Failure at Death or Discharge. European Journal of Heart Failure. 9(5). 491–501. 68 indexed citations

15.

Ланкин, В. З., Г. Г. Коновалова, А. К. Тихазе, et al.. (2007). Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus. Bulletin of Experimental Biology and Medicine. 143(2). 207–209. 10 indexed citations

16.

Køber, Lars, Karl Swedberg, John J.V. McMurray, et al.. (2006). Previously Known and Newly Diagnosed Atrial Fibrillation: A Major Risk Indicator After a Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction. European Journal of Heart Failure. 8(6). 591–598. 102 indexed citations

17.

Cleland, John G.F., Ferenc Folláth, Karl Swedberg, et al.. (2001). Variations in therapy for heart failure in Europe: from perceptions to practice. A study of over 1300 physicians and > 11,000 patients. European Heart Journal. 22. 536–536. 1 indexed citations

18.

Cleland, John G.F., Karl Swedberg, Alain Cohen‐Solal, et al.. (2000). The Euro Heart Failure Survey of The EUROHEART Survey Programme: A Survey on the Quality of Care Among Patients with Heart Failure in Europe. European Journal of Heart Failure. 2(2). 123–132. 110 indexed citations

19.

MIu, Samsonov, et al.. (1991). Serum neopterin--possible immunological marker of myocardial inflammation in patients with dilated heart muscle disease. European Heart Journal. 12(suppl D). 151–153. 9 indexed citations

20.

Агеев, Ф. Т., et al.. (1985). [Effects of ethmozine and ethacizin on the central hemodynamics, peripheral vascular tonus and tissue oxygenation in patients with ventricular rhythm disorders and cardiac insufficiency].. PubMed. 57(12). 52–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact